PF-04236921
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-04236921, covering 2010-11-23 to 2018-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis [Phase 1]